| Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis T Chitnis, F Qureshi, VM Gehman, M Becich, R Bove, BAC Cree, ... Nature Communications 15 (1), 4297, 2024 | | 2024 |
| An autoantibody signature predictive for multiple sclerosis CR Zamecnik, GM Sowa, A Abdelhak, R Dandekar, RD Bair, KJ Wade, ... Nature Medicine, 1-9, 2024 | 1 | 2024 |
| Synaptic injury in the inner plexiform layer of the retina is associated with progression in multiple sclerosis C Cordano, S Werneburg, A Abdelhak, DJ Bennett, A Beaudry-Richard, ... Cell Reports Medicine 5 (4), 2024 | 1 | 2024 |
| OLIKOS Study: 6-month Interim Efficacy and Safety in Patients with Relapsing Multiple Sclerosis Who Switched to Subcutaneous Ofatumumab from Intravenous Anti-CD20 Therapies … E Alvarez, B Brown, E Camacho, B Greenberg, R Henry, R Piccolo, L Hua Neurology 102 (17_supplement_1), 3173, 2024 | | 2024 |
| Susceptibility-based Imaging Aids Accurate Distinction of Pediatric-onset MS from Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (S42. 001) A Virupakshaiah, S Sacco, N Papinutto, V Schoeps, A Akula, H Zhao, ... Neurology 102 (17_supplement_1), 7050, 2024 | | 2024 |
| 3D balanced SSFP UTE MRI for multiple contrasts whole brain imaging X Shen, E Caverzasi, Y Yang, X Liu, A Green, RG Henry, U Emir, ... Magnetic Resonance in Medicine, 2024 | 1 | 2024 |
| Quantification of the in vivo brain ultrashort‐T2* component in healthy volunteers N Deveshwar, J Yao, M Han, N Dwork, X Shen, E Ljungberg, E Caverzasi, ... Magnetic Resonance in Medicine, 2024 | 1 | 2024 |
| Imaging chronic active lesions in multiple sclerosis: a consensus statement F Bagnato, P Sati, CC Hemond, C Elliott, SA Gauthier, DM Harrison, ... Brain, awae013, 2024 | 9 | 2024 |
| A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis L Daboul, CM O’Donnell, M Amin, P Rodrigues, J Derbyshire, C Azevedo, ... Multiple Sclerosis Journal 30 (1), 25-34, 2024 | 1 | 2024 |
| Neurofilament light chain elevation and disability progression in multiple sclerosis A Abdelhak, P Benkert, S Schaedelin, WJ Boscardin, C Cordano, ... JAMA neurology 80 (12), 1317-1325, 2023 | 13 | 2023 |
| Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease S Sacco, A Virupakshaiah, N Papinutto, VA Schoeps, A Akula, H Zhao, ... Multiple Sclerosis Journal 29 (14), 1736-1747, 2023 | 4 | 2023 |
| Elevated Serum Neurofilament Light Chain Precedes and Predicts Disease Progression in Multiple Sclerosis A Abdelhak, P Benkert, S Schadelin, WJ Boscardin, C Cordano, ... MULTIPLE SCLEROSIS JOURNAL 29, 95-96, 2023 | | 2023 |
| Susceptibility-based imaging aids accurate diagnosis of pediatric MS and myelin oligodendrocyte glycoprotein antibody-associated disease S Sacco, A Virupakshaiah, N Papinutto, A Akula, H Zhao, W Stern, ... MULTIPLE SCLEROSIS JOURNAL 29, 502-502, 2023 | | 2023 |
| OLIKOS Study: 6-Month Interim Efficacy and Safety in Patients With Relapsing Multiple Sclerosis Who Switched to Subcutaneous Ofatumumab From Intravenous Anti-CD20 Therapies LH Hua, B Brown, E Camacho, BM Greenberg, RG Henry, R Piccolo, ... Poster presented at the 9th Joint ECTRIMS-ACTRIMS Meeting 11, 13, 2023 | | 2023 |
| Recent glucocorticoid treatment decrease the rate of spinal cord pseudoatrophy in the first year after DMT start S Sacco, N Papinutto, S Cheng, A Akula, H Zhao, J Juwono, W Stern, ... MULTIPLE SCLEROSIS JOURNAL 29, 503-504, 2023 | | 2023 |
| Accelerated rate of grey matter brain atrophy after menopause in a longitudinal cohort of women with MS A Nylander, H Silverman, A Akula, A Bostrom, A Lazar, RC Gomez, ... MULTIPLE SCLEROSIS JOURNAL 29, 133-133, 2023 | | 2023 |
| Association of Baseline Spinal Cord Area and Brain Volume With Long-Term Disability Progression in Ozanimod-Treated Participants With Relapsing Multiple Sclerosis M Filippi, R Henry, DL Arnold, C Granziera, L Kappos, J Sheffield, ... MULTIPLE SCLEROSIS JOURNAL 29, 266-267, 2023 | | 2023 |
| Incorporation of the central vein sign into the International Panel criteria increases specificity and accuracy for a diagnosis of multiple sclerosis M Amin, K Nakamura, L Daboul, C O'Donnell, Q Cao, P Rodrigues, ... MULTIPLE SCLEROSIS JOURNAL 29, 509-510, 2023 | | 2023 |
| Myelin water fraction of the corpus callosum is a robust measure of remyelination in a double blind-placebo controlled clinical trial. C Cordano, E Caverzasi, N Papinutto, G Kirkish, T Gundel, A Zhu, A Akula, ... GLIA 71, E1101-E1102, 2023 | | 2023 |
| MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial E Caverzasi, N Papinutto, C Cordano, G Kirkish, TJ Gundel, A Zhu, ... Proceedings of the National Academy of Sciences 120 (20), e2217635120, 2023 | 18 | 2023 |
